Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 12:3:RRN1230.
doi: 10.1371/currents.RRN1230.

Advocacy Recruiting for Huntington's Disease Clinical Trials

Lavonne Goodman  1 , Cherrie Sia, Roger Carnes, Louise Vetter, Fred Taubman, Charles S Venuto, Andrew McGarry, Karl Kieburtz, Pinky Agarwal
Affiliations

Advocacy Recruiting for Huntington's Disease Clinical Trials

Lavonne Goodman et al. PLoS Curr. .

Abstract

Recent clinical trials for Huntington's disease (HD) have been slowed by the inability to complete enrollment in a timely manner. We report a successful advocacy-based recruiting approach at Evergreen Neuroscience Institute, a new Huntington Study Group (HSG) investigative site that lacked an HD patient base. By partnering with community advocates and utilizing web-based advocacy group alerts, Evergreen ranked third of 27 North American sites conducting the Study of ACR16 for the Treatment of Huntington's disease (HART) for number of participants, and first for rate of recruitment -- all while decreasing the time and financial resources needed for site-based recruiting. To our knowledge this is the first published outcome study for advocacy recruiting in any disease population.

PubMed Disclaimer

References

    1. Huntington Study Group. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology. 2001 Aug 14;57(3):397-404. - PubMed
    1. A Study of ACR16 for the Treatment of Patients With Huntington's Disease...
    1. Coenzyme Q10 in Huntington's Disease (HD)
    1. Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
    1. Veatch Goodman L, Guiliano J and Lovecky D. Survey of Clinical Trial Interest and Literacy in Huntington Support Groups: Northwest Pilot Project Neurotherapeutics 2009; 6:204.